Advertisement

Tuberculosis

  • George W. Comstock
  • Richard J. O’Brien

Abstract

The term “tuberculosis” is used primarily to signify an infectious disease of the lungs caused by Mycobacterium tuberculosis. Many other organs may be involved, however, and similar illnesses caused by M. bovis are also called tuberculosis. The disease has long been a major killer of mankind. In 17th century England, John Bunyan referred to consumption, now recognized as one of the forms of pulmonary tuberculosis, as “the captain of all of these men of death.” Tuberculosis is still a major cause of disability and premature death throughout most of the world today. Only among the economically favored nations has it become a relatively minor problem, concentrated among disadvantaged segments of the population.

Keywords

Tuberculin Skin Test Pulmonary Tuberculosis Tuberculosis Case Tuberculosis Control Nontuberculous Mycobacterium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Addington, W. W., Albert, R. K., Bass, J. B., Jr., Catlin, B. J., Loudon, R. G., Seggerson, J., and Slutkin, G., Non-drug issues related to the treatment of tuberculosis, Chest 87(2):125S-127S (1985).Google Scholar
  2. 2.
    American Thoracic Society, The tuberculin skin test, Am. Rev. Respir. Dis. 124:356–363 (1981).Google Scholar
  3. 3.
    American Thoracic Society, Treatment of tuberculosis and tuberculosis infection in adults and children, Am. Rev. Respir. Dis. 134:355–363 (1986).Google Scholar
  4. 4.
    Anderson, S., and Banerji, D., A sociological inquiry into an urban tuberculosis control programme in India, Bull. Who 29:685–700 (1963).Google Scholar
  5. 5.
    Armstrong, D. B., Four years of the Framingham Demonstration, Am. Rev. Tuberc. 4:908–919 (1921).Google Scholar
  6. 6.
    Centers for Disease Control, Tuberculosis Control Division, Extrapulmonary Tuberculosis in the United States, HEW Publ. (CDC) 78–8360 (1978).Google Scholar
  7. 7.
    Centers for Disease Control, Tuberculosis Control Division, Guidelines for Prevention of TB in Hospitals, Centers for Disease Control, Atlanta, 1983.Google Scholar
  8. 8.
    Centers for Disease Control, Division of Tuberculosis Control, 1985 Tuberculosis Statistics, States and Cities, HHS Publ. (CDC) 87–8249 (1986).Google Scholar
  9. 9.
    Centers for Disease Control, Division of Tuberculosis Control, Tuberculosis in the United States, 1981–1984, HHS Publ. (CDC) 86–8322 (1986).Google Scholar
  10. 10.
    Centers for Disease Control, Division of Tuberculosis Control, Tuberculosis final data-United States, 1986, Morbid. Mortal. Weekly Rep. 36:817–820 (1988).Google Scholar
  11. 11.
    Chapman, J. S., and Dyerly, M. D., Social and other factors in intrafamilial transmission of tuberculosis, Am. Rev. Respir. Dis. 90:48–60 (1964).PubMedGoogle Scholar
  12. 12.
    Chaves, A. D., Robins, A. B., and Abeles, H., Tuberculosis case finding among homeless men in New York City, Am. Rev. Respir. Dis. 84:900–901 (1961).PubMedGoogle Scholar
  13. 13.
    Cochrane, A. L., Jarman, T. F., Miall, W. E., and Carpenter, R. G., Factors influencing the attack rate of pulmonary tuberculosis, Thorax 11:141–148 (1956).PubMedGoogle Scholar
  14. 14.
    Comstock, G. W., Isoniazid prophylaxis in an undeveloped area, Am. Rev. Respir. Dis. 86:810–822 (1962).PubMedGoogle Scholar
  15. 15.
    Comstock, G. W., Frost revisited: The modern epidemiology of tuberculosis, Am. J. Epidemiol. 101:363–382 (1975).PubMedGoogle Scholar
  16. 16.
    Comstock, G. W., False tuberculin test results, Chest 68S:465S-469S (1975).Google Scholar
  17. 17.
    Comstock, G. W., Tuberculosis in twins: A re-analysis of the Prophit survey, Am. Rev. Respir. Dis. 117:621–624 (1978).PubMedGoogle Scholar
  18. 18.
    Comstock, G. W., Identification of an effective vaccine against tuberculosis, Am. Rev. Respir. Dis. 138:479–480 (1988).PubMedGoogle Scholar
  19. 19.
    Comstock, G. W., and Edwards, P. Q., The competing risks of tuberculosis and hepatitis for adult tuberculin reactors, Am. Rev. Respir. Dis. 111:573–577 (1975).PubMedGoogle Scholar
  20. 20.
    Comstock, G. W., and Sartwell, P. E., Tuberculosis studies in Muscogee County, Georgia. IV. Evaluation of a community-wide X-ray survey on the basis of six years of observation, Am. J. Hyg. 61:261–285 (1955).Google Scholar
  21. 21.
    Comstock, G. W., and Woolpert, S. F., Preventive therapy, in: The Mycobacteria: A Sourcebook (G. P. Kubica and L. W. Wayne, eds.), pp. 1071–1082, Dekker, New York, 1984.Google Scholar
  22. 22.
    Comstock, G. W., Ferebee, S. H., and Hammes, L. M., A controlled trial of community-wide isoniazid prophylaxis in Alaska, Am. Rev. Respir. Dis. 95:935–943 (1967).PubMedGoogle Scholar
  23. 23.
    Comstock, G. W., Livesay, V. T., and Woolpert, S. F., Evaluation of Bcg vaccination among Puerto Rican children, Am. J. Public Health, 64:283–291 (1974).PubMedGoogle Scholar
  24. 24.
    Comstock, G. W., Livesay, V. T., and Woolpert, S. F., The prognosis of a positive tuberculin reaction in childhood and adolescence, Am. J. Epidemiol. 99:131–138 (1974).PubMedGoogle Scholar
  25. 25.
    Comstock, G. W., Edwards, L. B., and Livesay, V. T., Tuberculosis morbidity in the U.S. Navy: Its distribution and decline, Am. Rev. Respir. Dis. 110:572–580 (1974).PubMedGoogle Scholar
  26. 26.
    Comstock, G. W., Woolpert, S. F., and Livesay, V. T., Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of Bcg vaccination, Public Health Rep. 91:276–280 (1976).PubMedGoogle Scholar
  27. 27.
    Comstock, G. W., Baum, C., and Snider, D. E., Jr., Isoniazid prophylaxis among Alaskan Eskimos: A final report of the Bethel isoniazid studies, Am. Rev. Respir. Dis. 119:827–830 (1979).PubMedGoogle Scholar
  28. 28.
    Curry, F. J., District clinics for out-patient treatment of tuberculosis problem patients, Dis. Chest 46:524–530 (1964).PubMedGoogle Scholar
  29. 29.
    Daniel, T. M., New approaches to the rapid diagnosis of tuberculous meningitis, J. Infect. Dis. 155:599–602 (1987).PubMedGoogle Scholar
  30. 30.
    Daniel, T. M., and Debanne, S. M., The serodiagnosis of tuberculosis and other mycobacterial diseases by enzymelinked immunosorbent assay, Am. Rev. Respir. Dis. 135:1137–1151 (1987).PubMedGoogle Scholar
  31. 31.
    Dash, L. A., Comstock, G. W., and Flynn, J. P. G., Isoniazid preventive therapy. Retrospect and prospect, Am. Rev. Respir. Dis. 121:1039–1044 (1980).PubMedGoogle Scholar
  32. 32.
    David, H. L., Bacteriology of the Mycobacterioses, Dhew Publ. (Cdc) 76–8316, U.S. Government Printing Office, Washington, D.C. (1976).Google Scholar
  33. 33.
    De Abreu, M., and De Paula, A., Roentgenfotografia, Livraria Ateneu, Rio de Janeiro, 1940.Google Scholar
  34. 34.
    Dickinson, J. M., Lefford, M. J., Lloyd, J., and Mitchison, D. A., The virulence in the guinea-pig of tubercle bacilli from patients with pulmonary tuberculosis in Hong Kong, Tubercle 44:446–451 (1963).PubMedGoogle Scholar
  35. 35.
    Donaldson, J. C., and Elliott, R. C., A study of copositivity of three multipuncture techniques with intradermal Ppd tuberculin, Am. Rev. Respir. Dis. 118:843–846 (1978).PubMedGoogle Scholar
  36. 36.
    Dubos, R., and Dubos, J., The White Plague: Tuberculosis, Man and Society, Little, Brown, Boston, 1952.Google Scholar
  37. 37.
    Edwards, L. B., Comstock, G. W., and Palmer, C. E., Contributions of northern populations to the understanding of tuberculin sensitivity, Arch. Environ. Health 17:507–516 (1968).PubMedGoogle Scholar
  38. 38.
    Edwards, L. B., Acquaviva, F. A., Livesay, V. T., Cross, F. W., and Palmer, C. E., An atlas of sensitivity to tuberculin, Ppd-B, and histoplasmin in the United States, Am. Rev. Respir. Dis. 99(4):Part 2 (1969).Google Scholar
  39. 39.
    Edwards, L. B., Livesay, V. T., Acquaviva, F. A., and Palmer, C. E., Height, weight, tuberculous infection, and tuberculous disease, Arch. Environ. Health 22:106–112 (1971).PubMedGoogle Scholar
  40. 40.
    Edwards, L. B., Acquaviva, F. A., and Livesay, V. T., Identification of tuberculous infected. Dual tests and density of reaction, Am. Rev. Respir. Dis. 108:1334–1339 (1973).PubMedGoogle Scholar
  41. 41.
    Enterline, P. E., and Kordan, B., A controlled evaluation of mass surveys for tuberculosis and heart disease, Public Health Rep. 73:867–875 (1958).PubMedGoogle Scholar
  42. 42.
    Fayers, P. M., and Barnett, G. D., The risk of tuberculous infection in Saskatchewan, Bull. Int. Union Tuberc. 50:62–69 (1975).PubMedGoogle Scholar
  43. 43.
    Ferebee, S. H., An epidemiological model of tuberculosis in the United States, Bull. Natl. Tuberc. Assoc. 53:4–7 (1967).Google Scholar
  44. 44.
    Ferebee, S. H., Controlled chemoprophylaxis trials in tuberculosis: A general review, Adv. Tuberc. Res. 17:28–106 (1970).Google Scholar
  45. 45.
    Fox, W., The current status of short-course chemotherapy, Tubercle 60:177–190 (1979).Google Scholar
  46. 46.
    Froggett, K., Tuberculosis: Spatial and demographic incidence in Bradford, 1980–2, J. Epidemiol. Community Health 39:20–26 (1985).Google Scholar
  47. 47.
    Frost, W. H., How much control of tuberculosis? Am. J. Public Health 27:759–766 (1937).Google Scholar
  48. 48.
    Grzybowski, S., Technical and operational appraisal of tuberculosis case-finding methods, in: II. Regional Seminar on Tuberculosis, Scientific Publ. 265, pp. 50–56, Pan American Health Organization, Washington, D.C., 1973.Google Scholar
  49. 49.
    Hart, P. D., and Sutherland, I., Bcg and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life, Br. Med. J. 2:293–295 (1977).PubMedGoogle Scholar
  50. 50.
    Holland, W. W., (ed.), European Community Atlas of ‘Avoidable Death,’ Oxford University Press, London, 1988x.Google Scholar
  51. 51.
    Horwitz, O., Tuberculosis risk and marital status, Am. Rev. Respir. Dis. 104:22–31 (1971).PubMedGoogle Scholar
  52. 52.
    Horwitz, O., and Comstock, G. W., What is a case of tuberculosis? The tuberculosis case spectrum in eight countries evaluated from 1235 case histories and roentgenograms, Int. J. Epidemiol. 2:145–152 (1973).PubMedGoogle Scholar
  53. 53.
    Horwitz, O., Wilbek, E., and Erickson, P. A., Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area, Bull. WHO 41:95–113 (1969).Google Scholar
  54. 54.
    Horwitz, O., Edwards, P. Q., and Lowell, A. M., National tuberculosis control program in Denmark and the United States, Health Serv. Rep. 88:493–498 (1973).PubMedGoogle Scholar
  55. 55.
    Houk, V. N., Baker, J. H., Sorensen, K., and Kent, D. C., The epidemiology of tuberculosis infection in a closed environment, Arch. Environ. Health 16:26–35 (1968).PubMedGoogle Scholar
  56. 56.
    Hyge, T. V., The efficacy of BCG vaccination, Acta Tuberc. Scand. 32:89–107 (1956).Google Scholar
  57. 57.
    International Union Against Tuberculosis Committee on Prophylaxis, Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the Iuat trial, Bull. Who 60:555–564 (1982).Google Scholar
  58. 58.
    Jarman, T. F., A follow-up tuberculin survey in the Rhondda Fach, Br. Med. J. 2:1235–1239 (1955).PubMedGoogle Scholar
  59. 59.
    Kamat, S. R., Dawson, J. J. Y., Devadatta, S., Fox, W., Janardhanam, B., Radhakrishna, S., Ramakrishnan, C. V., Somasundaram, P. R., Stott, H., and Velu, S., A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in south India, Bull. Who 34:517–532 (1966).PubMedGoogle Scholar
  60. 60.
    Kaplan, G. J., Fraser, R. I., and Comstock, G. W., Tuberculosis in Alaska, 1970. The continued decline of the tuberculosis epidemic, Am. Rev. Respir. Dis. 105:920–926 (1972).PubMedGoogle Scholar
  61. 61.
    Kielmann, A. A., Oberoi, I. S., Chandra, R. K., and Mehra, V. L., The effect of nutritional status on immune capacity and immune responses in preschool children in a rural community in India, Bull. Who 54:477–483 (1976).PubMedGoogle Scholar
  62. 62.
    Kopanoff, D. E., Snider, D. E., Jr., and Caras, G. J., Isoniazid-related hepatitis. A U.S. Public Health Service cooperative surveillance study, Am. Rev. Respir. Dis. 117:991–1001 (1978).PubMedGoogle Scholar
  63. 63.
    Kuemmerer, J. M., and Comstock, G. W., Sociologic concomitants of tuberculin sensitivity, Am. Rev. Respir. Dis. 96:885–892 (1967).PubMedGoogle Scholar
  64. 64.
    Lowell, A. M., Tuberculosis in the World, Hew Publ. (Cdc) 76–8317, U.S. Government Printing Office, Washington, D.C., 1976.Google Scholar
  65. 65.
    Lowell, A. M., Edwards, L. B., and Palmer, C. E., Tuberculosis, Harvard University Press, Cambridge, Mass., 1969.Google Scholar
  66. 66.
    Lurie, M. B., Resistance to Tuberculosis: Experimental Studies in Native and Acquired Defensive Mechanisms, pp. 115–180, Harvard University Press, Cambridge, Mass., 1984.Google Scholar
  67. 67.
    Magnus, K., Epidemiological basis of tuberculosis eradication. 6. Tuberculin sensitivity after human and bovine infection, Bull. Who 36:719–731 (1967).PubMedGoogle Scholar
  68. 68.
    Medical Research Council, Tuberculosis and Chest Diseases Unit, National survey of notifications of tuberculosis in England and Wales in 1983, Br. Med. J. 291:658–661 (1985).Google Scholar
  69. 69.
    Myers, J. A., Tuberculosis: A Half Century of Study and Conquest, pp. 222–241, Green, St. Louis, 1970.Google Scholar
  70. 70.
    National Tuberculosis Institute, Bangalore, Tuberculosis in a rural population in south India: A five-year epidemiological study, Bull. Who 51:473–488 (1974).Google Scholar
  71. 71.
    Nissen Meyer, S., Hougen, A., and Edwards, P., Experimental error in the determination of tuberculin sensitivity, Public Health Rep. 63:561–569 (1951).Google Scholar
  72. 72.
    Nyboe, J., Interpretation of tuberculosis infection age curves, Bull. Who 17:319–339 (1957).PubMedGoogle Scholar
  73. 73.
    Overfield, T., and Klauber, M. R., Prevalence of tuberculosis in Eskimos having blood group B gene, Hum. Biol. 52(1):87–92 (1980).PubMedGoogle Scholar
  74. 74.
    Padungchan, S., Konjanart, S., Kasiratta, S., Daramas, S., and Ten Dam, H. G., The effectiveness of Bcg vaccination of the newborn against childhood tuberculosis in Bangkok, Bull. Who 64:247–258 (1986).PubMedGoogle Scholar
  75. 75.
    Palmer, C. E., Ferebee, S. H., and Hopwood, L., Studies on prevention of experimental tuberculosis with isoniazid. II. Effects of different dosage regimens, Am. Rev. Respir. Dis. 74:917–939 (1956).Google Scholar
  76. 76.
    Perez-Stable, E. J., Slutkin, G., Pax, E. A., and Hopewell, P. C., Tuberculin reactivity in United States and foreign-born Latinos: Results of a community-based screening program. Am. J. Public Health 76:643–646 (1986).PubMedGoogle Scholar
  77. 77.
    Powell, K. E., Brown, E. D., and Farer, L. S., Tuberculosis among Indochinese refugees in the United States, J. Am. Med. Assoc. 249:1455–1460 (1983).Google Scholar
  78. 78.
    Puffer, R. R., Familial Susceptibility to Tuberculosis, Harvard University Press, Cambridge, Mass., 1944.Google Scholar
  79. 79.
    Pust, R. E., Onejeme, S. E., and Okafor, S. N., Tuberculosis survey in East Central State, Nigeria: Implications for tuberculosis programme development, Trop. Geogr. Med. 26:51–57 (1974).PubMedGoogle Scholar
  80. 80.
    Raj Narain, and Vallishayee, R. S., BCG vaccination of tuberculous patients and of strong reactors to tuberculin, Bull. Int. Union Tuberc. 51:243–246 (1976).PubMedGoogle Scholar
  81. 81.
    Raj Narain, Nair, S. S., Chandrasekhar, P., and Ramanatha Rao, G., Problems associated with estimating the incidence of tuberculosis infection, Bull. Who 34:605–622 (1966).PubMedGoogle Scholar
  82. 82.
    Raj Narain, Chandrasekhar, P., Satyanarayanachar, R. A., and Lal, P., Resistant and sensitive strains of Mycobacterium tuberculosis found in repeated surveys among a south Indian rural population, Bull. Who 39:681–699 (1968).PubMedGoogle Scholar
  83. 83.
    Raj Narain, Subba Rao, M. S., Chandrasekhar, P., and Pyarelal, Microscopy positive and microscopy negative cases of pulmonary tuberculosis, Am. Rev. Respir. Dis. 103:761–773 (1971).PubMedGoogle Scholar
  84. 84.
    Reichman, L. B., and O’Day, R., Tuberculous infection in a large urban population, Am. Rev. Respir. Dis. 117:705–712 (1978).PubMedGoogle Scholar
  85. 85.
    Rose, D. N., Schechter, C. B., and Silver, A. L., The age threshold for isoniazid chemoprophylaxis: A decision analysis for low-risk tuberculin reactors, J. Am. Med. Assoc. 256:2709–2713 (1986).Google Scholar
  86. 86.
    Ruben, F. L., Norden, C. W., and Schuster, A., Analysis of a community hospital employee tuberculosis screening program 31 months after its inception, Am. Rev. Respir. Dis. 115:23–28 (1977).PubMedGoogle Scholar
  87. 87.
    Rust, P., and Thomas, J., A method for estimating the prevalence of tuberculous infection, Am. J. Epidemiol. 101:311–322 (1975).PubMedGoogle Scholar
  88. 88.
    Sartwell, P. E., Moseley, C. H., and Long, E. R., Tuberculosis in the German population, United States Zone of Germany, Am. Rev. Tuberc. 59:481–493 (1949).PubMedGoogle Scholar
  89. 89.
    Sbarbaro, J., Skin test antigens: An evaluation whose time has come, Am. Rev. Respir. Dis. 118:1–5 (1978).PubMedGoogle Scholar
  90. 90.
    Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., and Friedland, G. H., A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection, N. Engl. J. Med. 320:545–550 (1989).PubMedGoogle Scholar
  91. 91.
    Shapiro, C., Cook, N., Evans, D., Willett, W., Fajardo, I., Koch-Weser, D., Bergonzoli, G., Bolanos, O., Guerrero, R., and Hennekens, C. H., A case-control study of Bcg and childhood tuberculosis in Cali, Colombia, Int. J. Epidemiol. 14:441–446 (1985).PubMedGoogle Scholar
  92. 92.
    Siddiqi, S. H., Hwangbo, C. C., Silcox, V., Good, R. C., Snider, D. E., Jr., and Middlebrook, G., Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species, Am. Rev. Respir. Dis. 130:634–640 (1984).PubMedGoogle Scholar
  93. 93.
    Smith, P. G., Retrospective assessment of the effectiveness of Bcg vaccination against tuberculosis using the case-control method, Tubercle 62:23–35 (1982).Google Scholar
  94. 94.
    Snider, D. E., Jr., and Cauthen, G. M., Tuberculin skin testing of hospital employees: Infection, “boosting,” and two-step testing, Am. J. Infect. Control 12:305–311 (1984).PubMedGoogle Scholar
  95. 95.
    Springett, V. H., The value of Bcg vaccination, Tubercle 46:76–84 (1965).PubMedGoogle Scholar
  96. 96.
    Stead, W. W., Undetected tuberculosis in prison, J. Am. Med. Assoc. 240:2544–2547 (1978).Google Scholar
  97. 97.
    Stead, W. W., Lofgren, J. P., Warren, E., and Thomas, C., Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes, N. Engl. J. Med. 312:1483–1487 (1985).PubMedGoogle Scholar
  98. 98.
    Sultan, L., Nyka, W., Mills, C., O’Grady, F., Wells, W., and Riley, R. L., Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients, Am. Rev. Respir. Dis. 82:358–369 (1960).PubMedGoogle Scholar
  99. 99.
    Sunderam, G., Mcdonald, R. J., Maniatis, T., Oleske, J., Kapila, R., and Reichman, L. B., Tuberculosis as a manifestation of the acquired immunodeficiency syndrome, J. Am. Med. Assoc. 256:362–366 (1986).Google Scholar
  100. 100.
    Sutherland, I., and Fayers, P. M., The association of the risk of tuberculous infection with age, Bull. Int. Union Tuberc. 50:70–81 (1975).PubMedGoogle Scholar
  101. 101.
    Sutherland, I., Styblo, K., Sampalik, M., and Bleiker, M. A., Annual risks of tuberculous infection in 14 countries, derived from the results of tuberculin surveys in 1948–1952, Bull. Int. Union Tuberc. 45:75–114 (1971).Google Scholar
  102. 102.
    Tuberculosis Prevention Trial, Madras, Trial of Bcg vaccines in south India for tuberculosis prevention, Indian J. Med. Res. 72(Suppl.):1–74 (1980).Google Scholar
  103. 103.
    Waaler, H., Galtung, O., and Mordal, K., The risk of tuberculous infection in Norway, Bull. Int. Union Tuberc. 50:5–61 (1975).PubMedGoogle Scholar
  104. 104.
    Wiegeshaus, E. H., Harding, G., Mcmurray, D., Grove, A. A., and Smith, D. W., A co-operative evaluation of test systems used to assay tuberculosis vaccines, Bull. Who 45:543–550 (1971).PubMedGoogle Scholar
  105. 105.
    Wilson, M. W., Fluorescence microscopy in examination of smears for Mycobacterium tuberculosis, Am. Rev. Tuberc. 65:709–717 (1952).Google Scholar
  106. 106.
    World Health Organization, Tuberculosis Research Office, Further studies of geographic variation in naturally acquired tuberculin sensitivity, Bull. Who 22:63–83 (1955).Google Scholar
  107. Suggested ReadingGoogle Scholar
  108. American Thoracic Society, Treatment of tuberculosis and tuberculosis infection in adults and children, Am. Rev. Respir. Dis. 134:355–363 (1986).Google Scholar
  109. Comstock, G. W., Frost revisited: The modern epidemiology of tuberculosis, Am. J. Epidemiol. 101:363–382 (1975).PubMedGoogle Scholar
  110. Dubos, R., and Dubos, J., The White Plague: Tuberculosis, Man and Society, Little, Brown, Boston, 1952.Google Scholar
  111. Edwards, P. Q., and Edwards, L. B., Story of the tuberculin test from an epidemiological viewpoint, Am. Rev. Respir. Dis. 81(1):Part 2 (1960).Google Scholar
  112. Ferebee, S. H., Controlled chemoprophylaxis trials in tuberculosis: A general review, Adv. Tuberc. Res. 17:28–106 (1970).Google Scholar
  113. Frost, W. H., How much control of tuberculosis? Am. J. Public Health 27:759–766 (1937).Google Scholar
  114. Supplement on future research in tuberculosis. Prospects and priorities for elimination, Am. Rev. Respir. Dis. 134:401–423 (1986).Google Scholar
  115. Thompson, N. J., Glassroth, J. H., Snider, D. E., Jr., and Farer, L. S., The booster phenomenon in serial tuberculin testing, Am. Rev. Respir. Dis. 119:587–597 (1979).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • George W. Comstock
    • 1
  • Richard J. O’Brien
    • 2
  1. 1.School of Hygiene and Public HealthThe Johns Hopkins UniversityUSA
  2. 2.Clinical Research Branch, Division of Tuberculosis Control, Center for Prevention Services, Centers for Disease ControlAtlantaUSA

Personalised recommendations